5Demetri GD, Benjamin RS, Blanke CD, et al. NCCN task force re- port: managementof patients with gastrointestinal strnmal tumor (GIST)--update of the NCCN clinical practiceguidelines [J]. J Natl Compr Cancer Netw, 2007,5 Suppl 2:S1-S29.
6Hornick JL, Fletcher CD. The role of KIT in themanagement of pa- tients with gastrointestinalstromal tumors [J]. Hum Pathol, 2007,38: 679-687.
7Lasota J, Stachura J, Miettinen M. GISTs with PDGFRA exon 14 mutations represent subset of clinically favorable gastric tumors with epithelioidmorphology[J].Lab Invest, 2006, 86:94-100.
8Heinrich MC, Corless CL, Duensing A, et al. PDGFRα activating mutations in gastroingestinal stromal tumors [J]. Science, 2003,299: 708-710.
9Hirota S, Ohashi A, Nishida T, et al. Gain-of-function mutations of platclet-derived growth factor receptor alpha gene in gastrointestinal stromal tumors[J]. Gastroenterology, 2003,125:660-667.
10Gelen T, Elpek GO, Aksoy NH, et al. p27 labeling index andpro- liferation in gastrointestinal stromal tumors: correlations withclini- copathologic factors and recurrence [J]. Jpn J Clin Oncol, 2003,33 (7):346-352.
二级参考文献23
1Grimberg A,Cohen P. Role of insulin-like growth factors and their binding proteins in growth control and carcinogenesis[J]. J Cell Physiol,2000,183(1):1-9.
2Mohan S, Baylink DJ. IGF-binding proteins are multifunctional and act via IGF-dependent and independent mechanisms[J]. J Endocrinol,2002,175(1):19-31.
3Firth SM, Baxter RC. Cellular actions of the insulin-like growth factor binding proteins[J]. Endocrine Reviews, 2002, 23(6):824-854.
4Lee KW, Cohen P. Nuclear effects: unexpected intracellular actions of insulin-like growth factor binding protein-3[J]. J Endocrinol, 2002, 175(1): 33-40.
5Zhou R, Diehl D, Hoeflich A et al. IGF-binding protein-4: biochemical characteristics and functional consequences[J]. J Endocrinol,2003,178(2): 177-193.
6Clemmons DR. Use of mutagenesis to probe IGF- binding protein structure/function relationships[J]. Endocrine Reviews,2001, 22(6):800-817.
7Miyakoshi N, Richman C, Qin X et al. Effects of recombinant insulin-like growth factor-binding protein-4 on bone formation parameters in mice[J]. Endocrinology, 1999,140(2):5719-5728.
8Gleeson LM, Chakrabotty C, McKinnon T et al. Insulin-like growth factor-binding protein 1 stimulates trophoblast migration by signaling through alpha 5 beta 1 integrin via mitogen-activated protein kinase pathway[J]. J Clin Endocrinol Metab, 2001,86(6):2484-2493.
9Liu B, Lee HY, Weinzimer SA et al. Direct functional interactions between insulin-like growth factor-binding protein-3 and retinoid X receptor-alpha egulate transcriptional signaling and apoptosis[J]. J Biol Chem, 2000,275(43):33607-33613.
10Richman C, Baylink DJ, Lang K et al. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo[J]. Endocrinology, 1999,140(10):4699-4705.
